Literature DB >> 11464860

Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma.

N Gross1, K Balmas, C Beretta Brognara, J Tschopp.   

Abstract

BACKGROUND AND PROCEDURE: To determine the possible role of Fas/FasL system in the particularly heterogeneous behaviour of neuroblastoma (NB), we have measured the functional expression of Fas and its ligand, FasL, in primary neuroblastoma samples and cell lines by immunohistochemistry and flow cytometry.
RESULTS: Our results reveal that while Fas expression is associated with low stage and more mature tumors, heterogeneous FasL expression was mostly detected in high stage tumors, with our apparent correlation to MYCN amplification. Flow cytometric analysis of cell lines demonstrated a high expression of Fas in epithelial-type, HLA class I positive cell lines, which was lost upon activation with phorbol esters. In contrast, Fas ligand was detected in only a small subset of cell lines.
CONCLUSIONS: In some cell lines, cytotoxic assays revealed the ability of NB-associated Fas receptor to transduce an apoptotic signal upon triggering. The pattern of functional Fas/FasL expression in tumours and cell lines suggests that this system may be involved in the evasion of highly malignant neuroblastoma cells to host immune response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11464860     DOI: 10.1002/1096-911X(20010101)36:1<111::AID-MPO1026>3.0.CO;2-3

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  5 in total

1.  Neuroblastoma cells negative for CD44 possess tumor-initiating properties.

Authors:  Elena K Siapati; Erasmia Rouka; Despina Kyriakou; George Vassilopoulos
Journal:  Cell Oncol (Dordr)       Date:  2011-03-22       Impact factor: 6.730

2.  Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.

Authors:  Prajitha Mohandas Edathara; Manjula Gorre; Sailaja Kagita; Sugunakar Vuree; Anuradha Cingeetham; Santhoshi Rani Nanchari; Phanni Bhushann Meka; Sandhya Annamaneni; Raghunadha Rao Digumarthi; Vishnupriya Satti
Journal:  Tumour Biol       Date:  2015-11-13

3.  NF-κB regulates caspase-4 expression and sensitizes neuroblastoma cells to Fas-induced apoptosis.

Authors:  Hai-Jie Yang; Mian Wang; Lei Wang; Bin-Feng Cheng; Xiao-Yu Lin; Zhi-Wei Feng
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

4.  Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.

Authors:  Wei Han; Yuling Zhou; Rong Zhong; Chen Wu; Ranran Song; Li Liu; Li Zou; Yan Qiao; Kan Zhai; Jiang Chang; Liming Huang; Li Liu; Xuzai Lu; Jiao Lou; Dianke Yu; Wen Tan; Jinzhe Zhang; Huanmin Wang; Xiaoping Miao
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

5.  Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Authors:  Anneleen Decock; Maté Ongenaert; Jasmien Hoebeeck; Katleen De Preter; Gert Van Peer; Wim Van Criekinge; Ruth Ladenstein; Johannes H Schulte; Rosa Noguera; Raymond L Stallings; An Van Damme; Geneviève Laureys; Joëlle Vermeulen; Tom Van Maerken; Frank Speleman; Jo Vandesompele
Journal:  Genome Biol       Date:  2012-10-03       Impact factor: 13.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.